The global Diagnostic Radiopharmaceuticals and Contrast Media Market is estimated to be valued at US$ 6,811.4 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Diagnostic radiopharmaceuticals and contrast media are substances that are used during medical imaging procedures to provide enhanced images of internal organs and structures of the body. ... Read more
